Publication of the Society for Experimental Mechanics. Contain reports on applications in the field of stress analysis in engineering and mechanical design. Designed for the practicing engineer or technician who must find ingenious means to collect testing and measurement data. Also offers the information on the latest commercially available hardware and software.

Published primarily for mechanical, chemical, aerospace and nuclear engineers. Emphasizes experimental work that enhances basic understanding of heat transfer, thermodynamics, fluid mechanics, and their applications. Covers topics such as combined heat and mass transfer, multiphase flow, combustion, radiative transfer, porous media, cryogenics, turbulence, contact resistance and thermophysical property measurements and techniques.

Most of my marketing experiments have failed. But, some have succeeded. From spending tens of thousands of dollars on print ads to hiring a Harvard data nerd to run Facebook campaigns, it's quite possible I've experimented more in the last five years than the average advisor has in their entire career. And this is just the beginning. Join me as I explore the world of marketing in the financial planning industry. Follow along as I experiment with different ideas, share my successes and failures, and interview outside-the-box experts.

Expert Authority Effect'NC/ Interviews is the Top 100 Entrepreneurship podcast where 2x #1 International Best Selling Author, Speaker & CEO Mario Fachini interviews industry-leading authors & experts and has them share their best publishing, marketing, and business strategies so you can learn how to implement them in your own business. Now's YOUR time, so prepare to shine!

The Experts Edge Podcast is where experts come to command the stage, position themselves as authorities, and scale their business up. Join host Colin Boyd, as he discusses influence, persuasion, and communication with the industry's leading experts. Are you ready to increase your influence and leverage your passion into a successful business? You're in the right place.

Designed as a results-oriented resource for plaintiff and defense lawyers. Tracks the latest state and federal news and support relating to expert evidence. Coverage includes court rulings on discoverability, admissibility and sufficiency of expert evidence; legislative proposals and changes to federal laws. Offers case studies, reports on trends and developments, discussion forums, as well as courtroom tips.

Expert Market is an online platform expert in supplies, software, and services for business.

Welcome to Expert on Nothing with Natasha Wakefield--a space for the curious and those on a journey to becoming their best selves. From fitness and mental health to relationships, beauty and everything in between, I ask the questions you're thinking, so you don't have to

Impact Factor: 4.9 (2024) Aims of the journal: It provides a forum for the commentary and analysis of drug discovery in the post-genomic era, with emphasis placed on the current and emerging disciplines involved and strategic planning. It is international, MEDLINE-indexed and peer-reviewed that publishes review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. Content: It covers chemoinformatics reviews - bioinformatics; assay development; novel screening technologies, in vitro/in vivo models, structure-based drug design, systems biology and drug case histories examining the steps involved in the preclinical and clinical development. Readership: Scientists and healthcare and pharmaceutical managers, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents.

Impact Factor: 0.464 (© 2015 Thomson Reuters, Journal Citation Reports®) Circulation: The Publisher does not disclose the circulation. Aims of the Journal: Expert Opinion on Orphan Drugs is an international, peer-reviewed journal that covers all aspects of R&D on rare diseases and orphan drugs. The Editors welcome: Reviews that focus on rare diseases or orphan drugs, and report on any of the following topics: diagnostics, pharmacogenomics and screening; prevalence and epidemiology (with particular attention to regional variations); drug development; lead generation and discovery; early or late phase clinical trials; regulatory issues; post-marketing safety; treatment outcomes. Drug Evaluations specifically reviewing the pharmacological properties; clinical potential/clinical efficacy; safety and, if applicable, HE/OR data on a particular orphan drug. Original Research papers reporting the results of early or late stage clinical investigations or HE/OR data on orphan drugs and studies in the treatment of rare diseases. Editorials, commentaries and meeting-highlights papers covering topics in rare diseases. Instructions for Authors / Submission Guidance: This can be found here